Gerresheimer (GRRMF) News Today $70.55 -3.40 (-4.60%) As of 03:18 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period KKR drops out of consortium seeking Gerresheimer takeover, Bloomberg News reportsApril 3 at 3:54 PM | reuters.comGerresheimer downgraded to Sector Weight from Overweight at KeyBancMarch 31 at 6:04 PM | markets.businessinsider.comKKR, Warburg Pincus consortium offers to acquire Gerresheimer, Reuters saysMarch 17, 2025 | markets.businessinsider.comExclusive: KKR, Warburg Pincus group submitted non-binding bid for Gerresheimer, sources sayMarch 17, 2025 | reuters.comKKR, Warburg Picus in talks to acquire Gerresheimer - BloombergMarch 13, 2025 | msn.comWarburg Pincus, KKR in talks to buy medical packaging maker Gerresheimer, Bloomberg News reportsMarch 12, 2025 | reuters.comGerresheimer price target lowered to EUR 94 from EUR 96 at Deutsche BankMarch 4, 2025 | markets.businessinsider.comGerresheimer price target raised to EUR 122.50 from EUR 111.40 at JPMorganFebruary 27, 2025 | markets.businessinsider.comGerresheimer AG (GRRMF) Q4 2024 Earnings Call TranscriptFebruary 26, 2025 | seekingalpha.comGerresheimer slashes revenue guidance for 2025 in halfFebruary 26, 2025 | reuters.comGerresheimer price target lowered to EUR 96 from EUR 110 at Deutsche BankFebruary 20, 2025 | markets.businessinsider.comGerresheimer draws interest from Phillips-Medisize and Bain, Bloomberg News reportsFebruary 19, 2025 | reuters.comGerresheimer upgraded to Buy from Hold at DZ BankFebruary 17, 2025 | markets.businessinsider.comBernstein Reaffirms Their Buy Rating on Gerresheimer (0NTI)February 11, 2025 | markets.businessinsider.comGerresheimer bestätigt Gespräche mit kaufwilligen InvestorenFebruary 9, 2025 | finanznachrichten.deGerman Packaging Firm Gerresheimer Is Said to Explore SaleFebruary 9, 2025 | finance.yahoo.comIs Gerresheimer AG (ETR:GXI) Trading At A 43% Discount?February 9, 2025 | finance.yahoo.comEQS-Adhoc: Gerresheimer AG confirms discussions with private equity investors on potential takeover offerFebruary 7, 2025 | markets.businessinsider.comGerman packaging firm Gerresheimer exploring sale, Bloomberg News reportsFebruary 7, 2025 | reuters.comSQ Innovation's Lasix ONYU With Gerresheimer On-body Drug Delivery Device Gets FDA ApprovalDecember 16, 2024 | markets.businessinsider.comBernstein Sticks to Its Buy Rating for Gerresheimer (0NTI)December 14, 2024 | markets.businessinsider.comEQS-News: Gerresheimer successfully completes acquisition of Blitz LuxCo Sarl, the holding company of the Bormioli Pharma GroupDecember 11, 2024 | markets.businessinsider.comJ.P. Morgan Remains a Buy on Gerresheimer (0NTI)December 6, 2024 | markets.businessinsider.comUBS Reaffirms Their Buy Rating on Gerresheimer (0NTI)November 30, 2024 | markets.businessinsider.comBernstein Remains a Buy on Gerresheimer (0NTI)November 26, 2024 | markets.businessinsider.comGerresheimer AG (ETR:GXI) is a favorite amongst institutional investors who own 70%November 25, 2024 | uk.finance.yahoo.comGerresheimer (0NTI) Gets a Buy from Kepler CapitalOctober 17, 2024 | markets.businessinsider.comJ.P. Morgan Reaffirms Their Buy Rating on Gerresheimer (0NTI)October 11, 2024 | markets.businessinsider.comGerresheimer shares jump as activist investor buys over 5% stakeOctober 9, 2024 | reuters.comGerresheimer (0NTI) Receives a Buy from Kepler CapitalOctober 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for Gerresheimer Despite Short-Term Challenges: A Long-Term Growth PerspectiveOctober 1, 2024 | markets.businessinsider.comGerresheimer-Aktienausblick aufgrund von Verzögerungen bei der Markterholung und Produktionsstopp gesenktOctober 1, 2024 | de.investing.comEQS-Adhoc: Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025September 30, 2024 | markets.businessinsider.comGerresheimer Lowers FY24 OutlookSeptember 30, 2024 | markets.businessinsider.comGerresheimer (0NTI) Gets a Buy from J.P. MorganSeptember 21, 2024 | markets.businessinsider.comGerresheimer AG (GXI.F)September 18, 2024 | sg.finance.yahoo.comDeutsche Bank Remains a Buy on Gerresheimer (0NTI)September 16, 2024 | markets.businessinsider.comGerresheimer AG (GXI.HA)August 22, 2024 | uk.finance.yahoo.comGerresheimer Announces Expansion Of Manufacturing Capabilities In Peachtree CityMay 27, 2024 | markets.businessinsider.comEQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass businessMay 23, 2024 | markets.businessinsider.comGerresheimer stock jumps on news it will acquire Blitz LuxCoMay 23, 2024 | za.investing.comGerresheimer In Deal With RxCap To Offer Connected Adherence Solutions; Buys Minority StakeApril 29, 2024 | markets.businessinsider.comGerresheimer grows Q1 organic revenue by 2.8%April 11, 2024 | msn.comEQS-News: Gerresheimer makes solid start to the financial year 2024April 11, 2024 | markets.businessinsider.comGerresheimer supplies 'key players' in GLP-1 drugs market, CEO saysApril 11, 2024 | reuters.comGerresheimer expects sales boost from burgeoning obesity drugs sectorApril 11, 2024 | reuters.comGerresheimer Q1 Profit Edges Down, Adj. EBITDA Up; Backs FY24 View, Sees Growth AheadApril 11, 2024 | markets.businessinsider.comInternational Companies Drive Diabesity InnovationMarch 29, 2024 | seekingalpha.comWeight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO saysMarch 29, 2024 | reuters.comGerresheimer price target raised by EUR 5 at BarclaysFebruary 26, 2024 | realmoney.thestreet.com Remove Ads Get Gerresheimer News Delivered to You Automatically Sign up to receive the latest news and ratings for GRRMF and its competitors with MarketBeat's FREE daily newsletter. Email Address GRRMF Media Mentions By Week GRRMF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRRMF News Sentiment▼-0.720.60▲Average Medical News Sentiment GRRMF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRRMF Articles This Week▼20▲GRRMF Articles Average Week Remove Ads Get Gerresheimer News Delivered to You Automatically Sign up to receive the latest news and ratings for GRRMF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ANSLY News Today ANSLF News Today CZMWY News Today CLPBF News Today CNVVY News Today FSPKF News Today LUCYW News Today NNCSF News Today OLYMY News Today CEOS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GRRMF) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredWhy Elon Musk Is Investigating Fort KnoxWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gerresheimer AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Gerresheimer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
